Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases-Reference-Cited by-同舟云学术

Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases

Published:1992-01 Issue:1 Volume:22 Page:33-40
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Maxon Harry R.,Thomas Stephen R.,Hertzberg Vicki S.,Schroder Louis E.,Englaro Emanuela E.,Samaratunga Ranasinghange,Scher Howard I.,Moulton Jonathan S.,Deutsch Edward A.,Deutsch Karen F.,Schneider Harold J.,Williams Craig C.,Ehrhardt Gary J.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference30 articles.

1. The palliation of symptomatic osseous metastases: Final results of the study by the Radiation Therapy Oncology Group;Tong;Cancer,1982

2. Single dose half-body irradiation for palliation of multiple bone metastases from solid tumors: Final Radiation Therapy Oncology Group report;Salazar;Cancer,1986

3. Bone radiopharmaceuticals;Spencer,1986

4. Preparation of 186-rhenium labelled HEDP and its possible use in the treatment of osseous neoplasms;Mathieu;Int J Appl Radiat Isot,1979

5. Preparation of Re-186 perrhenate for nuclear medical purposes;Eisenhut;Int J Appl Radiat Isot,1982

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basis of Therapeutic Nuclear Medicine;Synopsis of Pathophysiology in Nuclear Medicine;2023

2. Dosing Therapeutic Radiopharmaceuticals in Obese Patients;International Journal of Molecular Sciences;2022-01-13

3. Basis of Therapeutic Nuclear Medicine;The Pathophysiologic Basis of Nuclear Medicine;2022

4. Dosimetry of bone seeking beta emitters for bone pain palliation metastases;Seminars in Nuclear Medicine;2021-12

5. Organometallic and coordination rhenium compounds and their potential in cancer therapy;Coordination Chemistry Reviews;2019-08